Botanix Pharmaceuticals to Raise About AU$40 Million via Share Placement; Shares Hit Three-Year Low

MT Newswires Live02-17 10:37

Botanix Pharmaceuticals (ASX:BOT) received firm commitments to raise about AU$40 million via a two-tranche placement of 666.7 million shares at AU$0.06 per share, according to a Tuesday filing with the Australian bourse.

The offer price represents an 45.5% discount to the stock's last traded price before the trading halt on Feb.13, the filing said.

Tranche one is expected to raise around AU$14.9 million by issuing 247.9 million shares at the offer price, while tranche two aims to raise about AU$25.1 million through the issue of 418.7 million shares, subject to shareholder approval, the filing added.

The company will also allow eligible shareholders to participate in a share purchase plan to raise up to AU$5 million at the same price, the company said.

Funds raised will be used towards the purchase of active pharmaceutical ingredient (API) and costs to obtain a second API supplier, the company added.

The new shares are expected to settle in early April.

Shares of the company fell 39% in recent Tuesday trade and earlier hit a three-year low.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment